Status:
UNKNOWN
A Survey to Assess Effects of Covid-19 on Cardiovascular Patients
Lead Sponsor:
Centro en Insuficiencia Cardiaca, Mexico
Collaborating Sponsors:
Instituto Nacional de Cardiologia Ignacio Chavez
Medica Sur Clinic & Foundation
Conditions:
Cardiovascular Diseases
Heart Failure
Eligibility:
All Genders
18-80 years
Brief Summary
The design included 152 patients with confirmed heart failure (HF) evaluated in two different periods of time: a baseline before the outbreak, and other during the outbreak of which 76 patients were r...
Detailed Description
Population and Data Sources All patients included, confirmed diagnosis of HF, according with the ESC guidelines criteria, both genders, above 18 years, who agreed to participate. All HF outpatients be...
Eligibility Criteria
Inclusion
- confirmed diagnosis of HF, according with the ESC guidelines criteria
- both genders,
- above 18 years,
- agreed to participate
Exclusion
- Impediment to contacting patients
- marked physical impairment
- cognitive impairment that prevents optimal interrogation
- Cultural barriers involving communication limitation (languages, dialects, reading and writing)
- Patient doesn't want to participate.
Key Trial Info
Start Date :
May 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 15 2021
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT04508920
Start Date
May 15 2019
End Date
July 15 2021
Last Update
August 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro de Insuficiencia Cardiaca Instituto Nacional de Cardiologia
Mexico City, Mexico, 14080